fludara 50mg powder for solution for injection or infusion
genzyme europe bv paasheuvelweg 25, 1105 bp amsterdam , netherlands - fludarabine phosphate - powder for solution for infusion or injection - fludarabine phosphate 25 mg/ml - antineoplastic agents
fludara oral 10mg film-coated tablets
genzyme europe bv paasheuvelweg 25, 1105 bp amsterdam , netherlands - fludarabine phosphate - film-coated tablet - fludarabine phosphate 10 mg - antineoplastic agents
tasermity
genzyme europe bv - sevelamer hydrochloride - hyperphosphatemia; renal dialysis - all other therapeutic products - tasermity is indicated for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis. sevelamer hydrochloride should be used within the context of a multiple therapeutic approach, which could include calcium supplements, 1,25 dihydroxy vitamin d3 or one of its analogues to control the development of renal bone disease.,
cerezyme 400unit powder for solution for infusion vials
genzyme therapeutics ltd - imiglucerase - powder for solution for infusion - 400unit
fabrazyme 5mg powder for solution for infusion vials
genzyme therapeutics ltd - agalsidase beta - powder for solution for infusion - 5mg
fabrazyme 35mg powder for solution for infusion vials
genzyme therapeutics ltd - agalsidase beta - powder for solution for infusion - 35mg
myozyme 50mg powder for concentrate for solution for infusion vials
genzyme therapeutics ltd - alglucosidase alfa - powder for solution for infusion - 50mg
aldurazyme (laronidase)
sanofi-aventis (malaysia) sdn. bhd. - laronidase -
cerezyme 400 unit
sanofi-aventis (malaysia) sdn. bhd. - imiglucerase -
fabrazyme 35mg injection
sanofi-aventis (malaysia) sdn. bhd. - recombinant human alfa galactosidase (r-hagal) -